Paeds · endocrinology-diabetes-and-growth
Precocious puberty
Also known as Central precocious puberty · GnRH-dependent precocious puberty · Peripheral precocious puberty · GnRH-independent precocious puberty · Premature sexual development
A fellowship approach to precocious puberty: recognise early sexual development as the onset of secondary sexual characteristics before 8 years in girls and before 9 years in boys, split it immediately into central (GnRH-dependent) and peripheral (GnRH-independent) forms plus the normal variants, confirm with bone age and a basal-then-stimulated gonadotropin work-up, and match the treatment to the driver — GnRH analog for central disease, cause-directed therapy for peripheral causes — because accelerated bone maturation and a missed central nervous system lesion are the two preventable harms.
On this page
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- Any boy with precocious puberty — a central nervous system lesion is found in roughly half or more, so brain MRI is mandatory
- Onset of secondary sexual characteristics before 6 years in a girl — high yield of organic disease, image the brain
- Virilisation (clitoromegaly, deepening voice, rapid muscle bulk) in a girl — points to a peripheral androgen source such as congenital adrenal hyperplasia or an adrenal or gonadal tumour
- Small prepubertal testes in a virilised boy — peripheral androgen source; a gonadotropin-releasing hormone analog will not help
- Rapidly progressive puberty with marked bone-age advancement — height potential is being lost and treatment is time-critical
- Headaches, visual disturbance, or new neurological signs in a child with early puberty — central nervous system tumour until proven otherwise
- Cafe-au-lait macules with a coarse border and bone pain or deformity — McCune-Albright syndrome driving peripheral puberty
Life stages
Care settings
Clinical exam formats
Board mappings
- Definition and thresholds of precocious puberty
- Central versus peripheral classification
- Indications for paediatric endocrine referral
- GnRH-dependent versus GnRH-independent mechanisms and investigation
- GnRH-analog therapy and cause-directed treatment of peripheral forms
- Brain-imaging triggers and the management of organic central causes
- Recognising and initially investigating early sexual development
- Tanner staging, bone age and the baseline endocrine panel
- Coordinating multidisciplinary surveillance and follow-up
- Long case of a child with progressive central precocious puberty
- Counselling a family on GnRH-analog treatment, height and psychosocial prognosis
- Disorders of puberty timing
- Endocrine investigation and the GnRH stimulation test
- Adolescent gynaecology and early puberty
- Central and peripheral precocious puberty mechanisms
- Investigation of early sexual development
- GnRH-analog and cause-directed management
- Tanner staging and growth-chart interpretation
- Counselling on the diagnosis and treatment of precocious puberty
- Precocious puberty diagnosis and management
- Central versus peripheral endocrine evaluation
- Congenital adrenal hyperplasia as a peripheral cause
- Precocious puberty
- Evaluation of early sexual development
- Multidisciplinary endocrine care of the child
- Disorders of puberty
- GnRH-analog therapy
- Transition and surveillance for syndromic causes
The fellowship mark goes to the candidate who refuses to treat the label "early puberty" and instead asks who is driving the axis. The child in front of you has breast budding or pubic hair and a growth spurt that worries the family, but the answer that decides every investigation and every drug sits upstream — in the hypothalamus and pituitary. If the axis is genuinely switched on, gonadotropins rise and a GnRH analog will switch it back off. If the axis is being bypassed by an autonomous ovary, testis, adrenal gland or exogenous steroid, gonadotropins are suppressed and a GnRH analog is useless. Holding that single distinction through the history, examination, laboratory panel and the counselling is what the examination rewards, because it is what protects the child's height and catches the CNS tumour. [1] [2]
Overview & Definition
Picture the parents who bring a six-year-old girl because they have noticed breast buds and a smell of body odour, or the four-year-old boy whose testicles have visibly grown. Each is asking the same question in a different body: has puberty started, and if it has, is it the real, central, gonadotropin-driven process or something mimicking it? Precocious puberty is the appearance of secondary sexual characteristics earlier than the accepted normal window — before 8 years in girls and before 9 years in boys — and it matters for two reasons that recur throughout the topic. First, unchecked sex steroids accelerate bone maturation and fuse the growth plates early, so the tall child becomes the short adult. Second, the early signal can be the first and only clue to a central nervous system lesion or an adrenal or gonadal source of autonomous hormone. [1] [2]
The definition carries a refinement that examiners probe deliberately. The traditional thresholds were chosen for their sensitivity, so they flag many girls whose course is benign and slowly progressive, particularly girls with higher body mass index and those of some ethnic backgrounds in whom thelarche naturally begins earlier. A practical refinement lowers the trigger for full evaluation: any girl with thelarche before 7 years (and some guidelines before 6 years) and any boy with any pubertal change at any age. The thresholds are a screening net, not a cliff edge — what matters is the tempo, the consonance of the sequence, and whether the bone age is running ahead of the child. [1] [2] [7]
References10ShowHide
- [1]Carel JC, Léger J. Clinical practice. Precocious puberty. N Engl J Med, 2008.PMID 18509122
- [2]Kaplowitz PB. Update on Precocious Puberty: Who Should Be Treated? Adv Pediatr, 2020.PMID 32591066
- [3]Bangalore Krishna K, Fuqua JS, Rogol AD, Klein KO, et al. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium. Horm Res Paediatr, 2019.PMID 31319416
- [4]Henley DV, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med, 2007.PMID 17267908
- [5]Rosenfield RL. Normal and Premature Adrenarche. Endocr Rev, 2021.PMID 33788946
- [6]Li Y, Ma T, Ma Y, Gao D, et al. Adiposity Status, Trajectories, and Earlier Puberty Onset: Results From a Longitudinal Cohort Study. J Clin Endocrinol Metab, 2022.PMID 35779008
- [7]Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME. Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics, 2001.PMID 11483799
- [8]Dumitrescu CE, Collins MT. McCune-Albright syndrome. Orphanet J Rare Dis, 2008.PMID 18489744
- [9]Speiser PW, Arlt W, Auchus RJ, Baskin LS, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2018.PMID 30272171
- [10]Klein KO, Mauras N, Nayak S, Sunil B, Soliman AM, Kansra AR. Long-term Safety, Efficacy, and PROs: Phase 3 Study of Leuprolide Acetate 6-month IM Depot in Central Precocious Puberty. J Endocr Soc, 2026.PMID 41623908